(updated 26 June 2019)

Current Funded Research

Co-Investigator:  Identification of gene-gene interactions in  relation to risk of esophageal adenocarcinoma and Barrett’s esophagus.  $93,000 (total direct), National Cancer Institute 2018-2020. (Matthew  Buas, PI, Roswell Park Cancer Institute.)

Co-Investigator:  Controlling Esophageal Cancer: A Collaborative  Modeling Approach. $170,000 (total direct subcontract). National Cancer  Institute, 2015-2020 (C. Hur, G. Luebeck, J. Inadomi, MPI)

Past Funded Research

Principal Investigator:  Established Investigator  Award in Cancer Epidemiology and Prevention. $830,000 (total direct),  National Cancer Institute. 2012-2018.

Co-Investigator:  Genomic studies for understanding etiology of  esophageal adenocarcinoma. $275,000 (total direct). National Cancer  Institute, 2015-2017. (J. Dai, PI)

Co-Investigator:  Post GWA analysis of inflammation pathways in  Barrett’s and esophageal cancer. $246,000 (total direct), National  Institute of Diabetes and Digestive and Kidney Diseases. 2014-2017. (M.  Madeleine, PI)

Co-Investigator:  Barrett’s esophagus: Predictors of progression.  $8,515,779 (total direct). National Cancer Institute. 2014-2019.  (Program Project PI, B. Reid).
Project leader, Project  2, Tools for Evidence-based Clinical Decision-making in Barrett’s  Esophagus. $869,581 (total direct for Project 2 of above P01). (Project leadership changed to Xiohong Li in 2017)

Co-Investigator:  (PQA1) Aspirin and Inflammation: Mutations, Genes,  Pathways and Prevention. $1,352,000 (total direct), National Cancer  Institute. 2013-2017. (B. Reid, PI)

Co-Investigator:  CRN4 – Cancer Research Resources &  Collaboration in Integrated Health Care Systems. $13,803,903 (total  direct), National Cancer Institute 2012-2017. (Lawrence Kushi, PI,  Kaiser Permanente Research Institute.)

Principal Investigator:  Metabolite biomarkers in  the development of esophageal adenocarcinoma. $248,000 (total direct),  National Cancer Institute. 2013-2016.

Principal Investigator:  Cancer Epidemiology and  Biostatistics Training Grant. $3,148,000 (total direct), National Cancer  Institute. 2012-2017. (PI-ship transferred to Dr. Stephen Schwartz in  May 2016.)

Consultant: Esophageal Cancer in the US: A Comparative Modeling  Project. $132,343 (total direct subcontract), National Cancer Institute,  2010-2015. (G. Luebeck, Consortium PI).

Principal Investigator: Barrett’s and Esophageal  Adenocarcinoma Consortium Genetics Susceptibility Study (BEAGESS).  $6,610,000 (total direct costs), National Cancer Institute. 2009-2014.   (D. Whiteman, Multiple PI).

Co-Investigator: Gene-environment EBV interactions in the etiology of  NPC. $1,994,000 (total direct costs). National Cancer Institute,  2008-2014. (H-O. Adami, PI).

Co-Investigator: Barrett’s esophagus: Predictors of progression.  $7,896,000 (total direct costs). National Cancer Institute. 2007 – 2013.  (Program Project PI, B. Reid). Project leader, Project 2, Epidemiology of progression in Barrett’s esophagus. $864,000 (total direct costs for Project 2 of above P01.)

Principal Investigator: Established Investigator Award in Cancer Epidemiology and Prevention. $737,000, National Cancer Institute. 2007-2012.

Consortium Principal Investigator: Adipokines and Barrett’s Esophagus. National Cancer Institute, 2010-2012. $463,000 (total direct costs) (D. Corley, PI).

Principal Investigator: Cancer Epidemiology and Biostatistics Training Grant. $3,210,465 (total direct), National Cancer Institute. 2007-2012.

Principal Investigator: ARRA Administrative  supplement to: Established Investigator Award in Cancer Epidemiology and  Prevention. $100,000  (total direct costs), National Cancer Institute,  2009-2011.

Consortium Principal Investigator: Role of the IGF  axis in the development of Barrett’s metaplasia: a pooled case-control  analysis from the Barrett’s Esophagus Adenocarcinoma Consortium  (BEACON). $250,000 (total direct costs). Cancer Research UK, 2008-2010.  (L. Hardie, PI).

Consortium Principal Investigator: Barrett’s  Esophagus: Risk Factors in Women. $225,000 (total direct costs).   National Institute of Diabetes and Digestive and Kidney Diseases, 2008 –  2010. (D. Corley, PI).

Director, Research Core 2 –  Environmental  Carcinogenesis. Center for Ecogenetics and Environmental Health.  $4,750,000. National Institute for Environmental Health Sciences. 2005 –  2008. (D. Eaton, PI).

Principal Investigator: Cancer Surveillance System.  $15,921,900. National Cancer Institute. 2003 – 2010. (Transferred  PI-ship to Stephen Schwartz in 2007.)

Co-Investigator: Barrett’s esophagus: Predictors of progression.  $8,907,000. National Cancer Institute. $8,780,000. 2002 – 2007. (Program  Project PI, Brian Reid).

Project leader, Project 2, Epidemiology of progression in Barrett’s esophagus. $977,756 (direct costs for Project 2 of above P01.)

Co-Investigator: Genetic Admixture and Confounding in Association  Studies. $800,000. National Cancer Institute. 2005-2007 (Hua Tang, PI).

Co-Investigator: Environmental Epidemiology training grant.  $3,000,000. National Institute for Environmental Health Science.  1996-2006. (Harvey Checkoway – PI).

Principal Investigator. Insulin-like Growth Factors & Esophageal Adenocarcinoma. $100,000. National Cancer Institute. 2002 – 2004.

Co-Investigator: Predictors of progression in Barrett’s esophagus.  $5,658,817. National Cancer Institute. 2001 – 2006. (Brian Reid, PI).  (subsumed within P01 after Year 07 in 2002).

Co-Principal Investigator: CARET – Chlamydia pneumoniae and risk of lung cancer. $225,000. National Cancer Institute. 2001 – 2003 (Gary Goodman, PI).

Principal Investigator:  Assessing and improving  quality of cancer surveillance data for American Indians. SEER Special  Study. $14,823. National Cancer Institute. 2000-2003.

Principal Investigator:  Cancer Surveillance System. Annual direct costs $1,070,000.  National Cancer Institute. 2001-2003.

Co-Investigator:  Carcinogen metabolizing enzyme genotypes and renal  cell carcinoma risk. $21,839.  UW Royalty Research Program. 1998-2000.   (Stephen Schwartz, PI).

Co-Investigator:  Epidemiology of p16 inactivation in Barrett’s  esophagus.  $675,041. National Cancer Institute. 1998-2001.  (Brian  Reid, PI).

Co-Investigator:  Polymorphisms in biotransformation enzymes and  renal cell carcinoma risk. $15,952.  UW Center for Ecogenetics (NIEHS  Center Grant P30 ES-07033, David Eaton – PI). 1998-1999.  (Diana Farrow –  PI).

Principal Investigator:  Esophageal and gastric  cancer in Huai’an County, China. $38,110. Cancer Prevention Research  Program Core, (P01 CA34847, Maureen Henderson – PI).  1997-2000.

Principal Investigator:  Polymorphisms in  biotransformation enzymes and risk of lung cancer.  $20,000.  University  of Washington, Center for Ecogenetics (NIEHS Center Grant P30 ES-07033,  David Eaton – PI). 1997-1999.

Principal Investigator:  Epidemiology of Barrett’s esophagus. $1,759,000. National Cancer Institute. 1997-2003.

Co-Investigator:  Mutagen sensitivity and progression in Barrett’s  esophagus. $849,810. National Cancer Institute. 1996-2000. (Diana Farrow  – PI).

Co-Investigator: GSTM1 and GSTT1 polymorphisms as risk factors for  renal cell carcinoma.  $20,000.  University of Washington, Center for  Ecogenetics (NIEHS Center Grant P30 ES-07033, David Eaton – PI).  1996-1997. (Diana Farrow – PI).

Co-Principal Investigator: Predictors of progression in Barrett’s  esophagus. $3,221,000. National Cancer Institute.  1995-2000.  (Brian  Reid – PI).

Co-Investigator: Epidemiology of glutathione transferase and lung  cancer. $955,000. National Cancer Institute. 1994-2000. (Valle  Nazar-Stewart – PI).

Principal Investigator: Epidemiologic study of adenocarcinomas of the esophagus and gastric cardia. $452,451.  National Cancer Institute.  1992-1996.

Principal Investigator: An epidemiologic study of lung cancer and wood exposure. $1,021,000. National Cancer Institute. 1992-1998.

Principal Investigator: Site of origin of metastatic  brain tumors – A pilot study.  $20,645.  National Cancer Institute  (supplement to ongoing SEER registry contract, David Thomas – PI).   1991-1992.

Co-Investigator: Environmental Epidemiology training grant. $850,000.  National Institute for Environmental Health Science. 1990-1996. (Harvey  Checkoway – PI).

Principal Investigator: An epidemiologic study of HLA type and nasopharyngeal cancer. $50,000. National Cancer Institute. 1989-1992.

Co-Investigator: Oral contraceptive use and risk of ulcerative  colitis. $350,000. National Cancer Institute. 1988-1992. (Edward Boyko –  PI).

Principal Investigator: An epidemiologic study of nasopharyngeal cancer. $350,000. National Cancer Institute. 1988-1993.

Co-Investigator: Landfill health survey. $13,000. City of Seattle. 1986. (Thomas Burbacher – PI).

Co-Investigator: Trace elements and cancers of the larynx, esophagus  and mouth. $230,000. National Cancer Institute. 1985-1991. (David Thomas  – PI).

Principal Investigator: The Selected Cancers among Vietnam Veterans Study. $276,000. Centers for Disease Control. 1985-1990.

Co-Investigator: Case-control study of cancers of larynx, esophagus  and oral cavity.  $650,000. National Cancer Institute. 1983-1988. (David  Thomas – PI).

Co-Investigator: Demonstration Health Surveillance System for  Department of Energy nuclear research facilities.  $2,000,000.  Department of Energy. 1982-1994. (J. Lee – PI).

Co-Investigator: Case-control study of formaldehyde and nasal and  pharyngeal cancer. $213,000. Environmental Protection Agency. 1982-1986.  (Janet Daling – PI).